SEC Form 4 · accession 0001960048-26-000009
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elvia Cowan
Officer — SVP, Finance & CAO
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 7:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 31, 2026 | F | 243 | $60.74 | D | 29,513 | D | |
| Common StockF1 | Sep 2, 2026 | F | 326 | $61.58 | D | 29,187 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.